This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

HomeHomeVaccines HomepageLoadingDisease AreasDisease AreasRespiratory Syncytial Virus (RSV)Pneumococcal diseaseTick-borne encephalitis (TBE)Meningococcal diseaseDisease Areas

Menu

Close

Our BrandsOur BrandsABRYSVO® (respiratory syncytial virus vaccine (bivalent, recombinant))APEXXNAR®(GB) (pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed))Nimenrix® (meningococcal groups A, C, W-135 and Y conjugate vaccine)Trumenba® (meningococcal group B vaccine (recombinant, adsorbed))Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed))TicoVac® (tick-borne encephalitis vaccine (whole virus inactivated))Vaccine TechnologiesVaccine TechnologiesMaternal ImmunisationConjugate TechnologyPolysaccharide VaccinesInactivated VaccinesSupport & ResourcesSupport & ResourcesClinic support materials
Polysaccharide Vaccines

Polysaccharide vaccines are a type of subunit vaccine, which are made from components of a pathogen, incapable of causing disease but specifically selected to help stimulate an immune response.1 Other examples of subunit vaccines also include conjugate vaccines and protein-based vaccines.

Polysaccharide vaccines contain chains of identical polysaccharides, which are sugar molecules derived from the surface of the target pathogen.2 This part of the pathogen is recognised as ‘foreign’ by the immune system, and is large enough so that an immune response is initiated.2,3 

The use of Polysaccharide Vaccines


Polysaccharide vaccines work well to protect against various types of infection, but this type of subunit vaccine may not work for all pathogens, as every pathogen is unique by nature.2

These vaccines offer a greater level of protection in older children and adults than in young children and infants, as the immature immune systems of younger children struggle to recognise and respond to these foreign polysaccharide antigens in order to mount an immune response.2,4


Pfizer does not offer subunit Polysaccharide Vaccines.

Therefore, to offer greater protection in younger children against infections that are more common in infancy, polysaccharide antigens may be conjugated to a carrier protein to form a conjugate vaccine, which enables the antigens to be delivered to cells that they would not be able to access without the protein.2

 

 
Pfizer currently offers three Polysaccharide Conjugate vaccines.

 
To learn more about Conjugate Technology and Pfizer's Polysaccharide Conjugate vaccines, click the button below.

 
Explore Conjugate TechnologyLoading
Order Clinic Materials

Help your customers to feel confident about vaccination - access MedISA to order printed clinic support materials to your surgery, pharmacy or other healthcare centre.

Order materials nowLoading
Register to receive personalised marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

Sign up hereLoading
References:

1. GAVI. What are protein subunit vaccines and how could they be used against COVID-19? Last accessed April 2023.
2.. GAVI. Making strides with polysaccharides: life-saving conjugate vaccines, explained. Last accessed April 2023.
3. Oxford Vaccine Group. Vaccine Knowledge Project. Types of vaccine. Last accessed April 2023

4. CDC. Understanding How Vaccines Work. Last accessed April 2023.​​
References:
  1. Public Health England. The Green Book [published 2013; updated 2020]. Chapter 25: Pneumococcal. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed: May 2022
  2. UPDATE REFERENCES
PP-UNP-GBR-4048. April 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​